» Authors » Gillian Watson

Gillian Watson

Explore the profile of Gillian Watson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 219
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fader M, MacAulay M, Wilson N, Goudie N, Chadwick T, Abouhajar A, et al.
BMJ Open . 2024 Dec; 14(8):e088483. PMID: 39645276
Introduction: Evaluating the safety and acceptability of reusing catheters for intermittent catheterisation (IC) is one of the top 10 continence research priorities identified by the UK James Lind Alliance Priority...
2.
3.
Abouhajar A, Alcock L, Bigirumurame T, Bradley P, Brown L, Campbell I, et al.
Trials . 2022 Sep; 23(1):789. PMID: 36127727
Background: Mitochondrial disease is a heterogenous group of rare, complex neurometabolic disorders. Despite their individual rarity, collectively mitochondrial diseases represent the most common cause of inherited metabolic disorders in the...
4.
Harding C, Chadwick T, Homer T, Lecouturier J, Mossop H, Carnell S, et al.
Health Technol Assess . 2022 May; 26(23):1-172. PMID: 35535708
Background: Daily, low-dose antibiotic prophylaxis is the current standard care for women with recurrent urinary tract infection. Emerging antimicrobial resistance is a global health concern, prompting research interest in non-antibiotic...
5.
Harding C, Mossop H, Homer T, Chadwick T, King W, Carnell S, et al.
BMJ . 2022 Mar; 376:e068229. PMID: 35264408
Objective: To test and compare the efficacy of methenamine hippurate for prevention of recurrent urinary tract infections with the current standard prophylaxis of daily low dose antibiotics. Design: Multicentre, open...
6.
Bourke J, Watson G, Spinty S, Bryant A, Roper H, Chadwick T, et al.
Neurol Clin Pract . 2021 Nov; 11(5):e661-e668. PMID: 34840880
Objective: To determine whether a combination of 2 heart medications would be tolerated and could prevent/delay the onset of cardiomyopathy in boys with Duchenne muscular dystrophy (DMD) compared with placebo....
7.
Cheetham T, Cole M, Abinun M, Allahabadia A, Barratt T, Davies J, et al.
J Clin Endocrinol Metab . 2021 Oct; 107(3):743-754. PMID: 34687316
Context: Remission rates in young people with Graves hyperthyroidism are less than 25% after 2 years of thionamide antithyroid drug (ATD). Objective: We explored whether rituximab (RTX), a B-lymphocyte-depleting agent,...
8.
Conradie W, Branch W, Watson G
Zootaxa . 2019 Nov; 4576(1):zootaxa.4576.1.1. PMID: 31715772
The Port Elizabeth Museum herpetology collection contains 407 type specimens, representing 70 primary and 55 secondary squamate types. The type series comprise 93 African taxa (84 lizards and 9 snakes),...
9.
OConnell N, Watson G, Grey C, Pastena R, McKeown K, David A
J Neuropsychiatry Clin Neurosci . 2019 Aug; 32(1):58-66. PMID: 31466518
Objective: No gold-standard treatment exists for motor functional neurological disorder (mFND), and limited evidence has been found for the effectiveness of cognitive-behavioral therapy (CBT) in treating the disorder. This study...
10.
Bourke J, Watson G, Muntoni F, Spinty S, Roper H, Guglieri M, et al.
BMJ Open . 2018 Dec; 8(12):e022572. PMID: 30573480
Introduction: Although cardiologists were 'late-comers' to the multidisciplinary team-contributing to the complex care of patients with Duchenne muscular dystrophy (DMD), they now recognise the importance of systematic cardiac surveillance and...